In order to emphasise the relevance of IL-6 downstream signalling and its role in cancer, we will primarily focus on the effects of the JAK/STAT3 signal transduction pathway, which has the ability to module tumour cell proliferation, survival, invasion, and metastasis, and thus is strongly associated with the progression of malignant disease. This evidence concerns the gene STAT3 and neoplasm.